NEWS

Pharmaceutical Industry news helps our clients to give competitive edge to their customers and also latest pharmaceutical industry news assists them in gaining updated knowledge. We bring you Global Pharmaceutical news about acquisitions, project undertakings, business and marketing, subjects, and industry related subjects, written in a professional, unbiased and thought-provoking format. Our international pharmaceutical News will help you enhance your business knowledge and productivity.

news

Danish drugmaker Novo Nordisk is looking to expand its obesity business in Latin America on the back of "phenomenal" performance by its new anti-obesity injection Saxenda, a senior company official said on Monday. Novo, the world's largest insulin maker, is betting on obesity to diversify its core diabetes business which…

news

The U.S. Food and Drug Administration approved Regeneron Pharmaceuticals and Sanofi's biotech drug for adults with moderate to severe rheumatoid arthritis, the two companies said on Monday. The drug, sarilumab, which will be sold under the brand name Kevzara, will carry a list price of $39,000 per year for the…

news

Drug firm Strides Shasun today said it has inked a pact with Vivimed Labs to set up two joint venture firms. The first JV -- a 50:50 joint venture company in India will own a USFDA approved formulation facility in Alathur, Chennai, Strides Shasun said in a regulatory filing. The…

news

Natco Pharma has received environment clearance (EC) for its Rs 480 crore expansion project in Telangana that would generate 1,500 jobs. The proposal is to increase the production capacity of 66 Active Pharmaceutical Ingredients (APIs) and API intermediates at a time with research and development activity from 115.5 tonnes per…

news

Recro Pharma presents Phase III bunionectomy clinical data for IV meloxicam at the American Pain Society 36th annual scientific meeting. Recro Pharma - data from late-stage trial demonstrate iv meloxicam 30mg provides rapid and sustained pain relief following bunionectomy surgery.   Source: reuters.com

news

India's drug pricing regulator has demanded explanations from 65 domestic and global drugmakers for selling new forms of essential diabetes and antibiotic drugs without its approval. The move could bring penalties for the drugmakers, among them Abbott Laboratories, Sanofi, Novartis and Indian firms such as Sun Pharmaceutical Industries and Lupin,…

news

Nearly 20 percent of patients with an aggressive form of leukemia experienced complete remission along with prolonged survival from treatment with an experimental Celgene Corp drug, according to data from an early-stage study released on Wednesday. The drug, enasidenib, delivered high overall response rates in patients with acute myeloid leukemia…

news

India's drug pricing regulator has issued a notice seeking explanation from companies found to be selling new versions of essential medicines without government approval on their pricing, a statement released on its website late on Wednesday showed. The move could result in penalties for several drugmakers, and is the latest…

news

Abon Pharmaceuticals, LLC, a specialty pharmaceutical company, today announced that it has received final approval from the FDA for its Abbreviated New Drug Application (ANDA) for Clofarabine Injection, 20 mg/20 mL, Single-use Vial. Clofarabine Injection is a generic equivalent of Genzyme's CLOLAR® Injection, a prescription medicine indicated for the treatment…

news

Astellas Pharma Inc. today announced that it has completed the acquisition of Ogeda SA (formerly named Euroscreen SA, "Ogeda"), a drug discovery company located in Gosselies, Belgium, and Ogeda has become a wholly owned subsidiary of Astellas as of CET May 17, 2017. Under the share purchase agreement executed between…

loadmore..